Cisplatin nephrotoxicity and protection by silibinin

Nephrology Dialysis Transplantation

Volumn 11, Issue 1, 1996, Pages 55-62

  Gaedeke, J ^a   Fels, L M ^a,b   Bokemeyer, C ^a   Mengs, U ^c   Stolte, H ^a   Lentzen, H ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b SysTA Biomed/GBM   (Germany)

^c Madaus AG   (Germany)

Author keywords

Cisplatin; Glomerulus; Nephroprotection; Nephrotoxicity; Silibinin; Tubular apparatus

Indexed keywords

CISPLATIN; CREATININE; FLAVONOID; MAGNESIUM; MICROSOMAL AMINOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE; SILIBININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; ENZYME ACTIVITY; ENZYMURIA; FEMALE; GLOMERULUS FILTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE FUNCTION; MICROSCOPY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SYMPTOM;

EID: 0030068254     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027066     Document Type: Article

References (40)

1. Osanto S, Bukman A, Van Hoek F, Sterk PJ, De Laat JA, Hermans J. Long term effect of chemotherapy in patients with testicular cancer J Clin Oncol 1992; 10: 574-579
2. Daugaard G, Abilgaard U, Holstein-Rathlou NH, Bruunshuus I, Bucher D, Leyssae PP. Renal tubular function in patients treated with high-dose cisplatin Clin Pharmacol Ther 1988; 44: 164-172
3. Field MJ, Bostrom TE, Seow F, Gyory AZ, Cockayne DJH. Acute cisplatin nephrotoxicity in the rat. Evidence for impaired entry of sodium into proximal tubule cells Pflugers Arch 1989; 414: 647-650
4. Ammer U, Natochin Y, David C, Rumrich G, Ullrich KJ. Cisplatin nephrotoxicity: Site of functional disturbance and correlation to loss of body weight. Renal Physiol Biochem 1993; 16: 131-145
5. Nosaka K, Nakada J, Endou H. Cisplatin-induced alterations in renal structure, ammoniagenesis and gluconeogenesis of rats. Kidney Int 1992; 41: 73-79
6. Daugaard G, Holstein-Rathlou NH, Leyssne PP. Effect of cisplatin on proximal convuluted and straight segments of the rat kidney. J Pharmacol Exp Ther 1988; 244: 1081-1085
7. Ishikawa M, Takayanagi Y, Sasuki KI. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathion-depleting agent, in mice. Res Comm Chem Pathol Pharmacol 1990; 67: 131-141
8. Hannemann J, Baumann K. Ciplatin-induced lipid peroxidation and decrease of gluconcogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicology 1988; 51: 119-132
9. McGinnes JE, Proctor PH, Demopoulos HB, Hokanson JA, Kirkpatrick DS. Amerlioration of cisplatinum nephrotoxicity by orgotein (superoxide dismutase). Physiol Chem Phys 1978; 10: 267-277
10. Tay LK, Bregman CL, Masters BA, Williams PD. Effects of cis-diaminedichloro-platinum (II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture. Cancer Res 1988; 48: 2538-2543
11. Yasumasu T, Ueda T, Uozomi J, Mihara Y, Kumazwa J Comparative study of cisplatin and carboplatin on pharmacokinetics nephrotoxicity and effect on renal nuclear DNA synthesis. Pharmacol Toxicol 1992; 70: 143-147
12. Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991; 91; 31S-38S
13. Valenzuela A, Lagos C, Schmidt K, Videla L. Sylimarin protection against hepatic lipid peroxidation induced by acute ethanol intoxication in rats. Biohem Pharmacol 1985; 34: 2209-2212
14. Valenzuela A u. Guerra R. Protective effect of the flavonoid silybin dihemisuccinate on the toxicity of phenylhydrazine on rat liver FEBS Lett 1985; 81: 291-294
15. Sonnenbichler J, Zell I. Stimulating influence of a flavolignane derivative on proliferation. RNA synthesis and protein synthesis in liver cells In: Okeliesanyi I, Csomos G, Crepadki G, eds. Assessment and Management of Hepatobiliary Diseases. Springer Verlag, Berlin, Heildelberg, 1987; 265-272
16. Soose M. Properties of silibinin and of antoxidants against adriamycin cytotoxicity in an unicellular eukaryote. Tetrahymena thermophila. Eur J Protisiol 1994; 30: 394-403
17. Middleton E, Kandaswami C. Effects of flavanoids on immune and inflammatory cell function. Biochem Pharmacol 1912; 43: 1167-1179
18. Hrushesky WJM, Levi FA, Halberg F, Kenedy BJ. Circadian stage dependence of cis-diamminodichloroplatinum lethal toxicity in rats. Cancer Res 1982; 42: 945-949
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72: 248-254
20. Weber MH, Verwiebe R, Neuhoff V, Scheler F. Analysis of proteinuria by micro-PAGE electropheresis. Contrib Nephrol 1988, 68: 179-187
21. Price RG. Urinary enzymes, nephrotoxicity and renal disease. Toxicology 1982; 23; 99-134
22. Magil AB, Mavichak V, Weng NLM, Quamme GA, Dirks JH, Sutton RAL. Long-term morphological and biochemical observations in cisplatin induced hypomagnesemia in rats. Nephron 1986; 43: 223-230
23. Mavichak V, Wang NLM, Quamme GA, Magil AB, Sutton RAL, Dirk JH. Studies on the pathogenesis of cisplatin induced hypomagnesium in rats. Kidney Int 1985; 28: 914-921
24. Soose M, Gwinner W, Gratkamp J, Hansemann W, Stolte H. Altered renal fibronectin exeretion in early adriamycin nephrosis of rats J Pharmacol Exp Ther 1991; 257: 493-499
25. Gwinner W, Jäckle-Meyer I, Stolte H. Origin of urinary fibronectin. Lab Invest 1993; 59; 250-255
26. Safirstein R, Miller P, Dikman S, Lyam N, Shapiro C. Cisplatin nephroroxicity in rats' defects in papillary hypertoxocity. Am J Physiol 1981; 241: F175-F185
27. Clifton GG, Pearce C, O'Neill W, Wallin JD. Early polyurin following a single-dose cis-dichlorodiamminoplatinum(II). J Lab Clin Med 1992, 100: 659-670
28. Gordon JA, Peterson LN, Anderson RJ. Water metabolism after cisplatin in the rat. Am J Physiol 1982; 243: F36-F43
29. Sadzuka Y, Shoij T, Takino A. Effects of cisplatin on the activity of enzymes which protect against lipid peroxidation. Biochem Pharmacol 1992; 43: 1872-1875
30. Fraga CS, Martino VS, Ferraro GE, Coussio JD, Boveris A. Flavonoids as anti-oxidants evaluated by in vitro and in situ liver chemoluminescence. Biochem Pharmacol 1987; 36: 717-720
31. Koya L, Bencsath P, Szenasi L et al. Effect of free radicals in ischemic renal failure in the dog. Acta Physiol Hung 1990; 76: 319-331
32. Sonnenbichler J, Mattersberger J, Rosen H. Stimulation of RNA synthesis in rat liver and in isolated hepatocyts by silibinin, an antihepatotoxic agent from sylibum marianum L. Gaertn. Hoppe-Seyler's Z Physiol Chem 1976; 357: 1171-1180
33. Jones TW, Chopra S, Kaufmann JS, Flamenbaum W, Trump WF. Cis-diamminedichloroplatinum (Il)-induced acute renal failure in the rat. Lab Invest 1985; 5: 363-374
34. Ferenci P, Dragnosics H, Ditrich H et al. Randomized controlled trial of sylimarin treatment in patients with cirrhosis of the liver. J Hepatol 1989: 105-113
35. Feher J, Lang I, Nekam K, Csomos G, Müzes G, Deak G. Effect of silibinin on the activity and expression of superoxide dismutase in lymphocytes from patients with chronic alcoholic liver disease. Free Rad Res Commun 1987; 3: 373-377
36. Szillard S, Szentgyorgyi D, Demeter I. Protective effect of legalon in workers exposed to organic solvents. Acta Med Hung 1988; 45: 249-56
37. Basinger MA, Jones MM, Holscher MA. L-methionine antagonism of cisplatinum nephrotoxicity. Toxicol Appl Pharmacol 1990; 103: 1-15
38. Anderson ME, Naganumba A, Meister A. Protection against cisplatin toxicity by administration of glutathione ester. FASEB J 1990; 4: 3251-3255
39. Aamdal S, Fodstad O, Pihl A. Some procedures to reduce cis-platinum toxicity reduce antitumor activity. Cancer Treat Rev. 1987; 14: 389-395
40. Dunn T, Voigt W, Bokemeyer C et al. Silibinin protects against cisplatin induced nephrotoxicity without compromising cisplatin or ifosfamide cytotoxicity. Ann Oncol 1994; 5 [suppl.8]: P916